Delayed stress-induced antinociceptive effect of nitric oxide synthase inhibition in the dentate gyrus of rats

Pharmacology Biochemistry and Behavior

Volumn 74, Issue 1, 2002, Pages 149-156

  Echeverry, Marcela B ^a   Guimarães, Francisco S ^a   Oliveira, Marina A ^a   Do Prado, William A ^a   Del Bel, Elaine A ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Analgesia; Antinociception; Hippocampus; Nitric oxide; Restraint stress; Stress induced analgesia; Tail flick

Indexed keywords

ARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN REGION; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; DRUG ANTAGONISM; ENZYME INHIBITION; HIPPOCAMPUS; IMMOBILIZATION STRESS; LATENT PERIOD; MALE; NEUROMODULATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TAIL FLICK TEST;

ANIMALS; DENTATE GYRUS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; MALE; MICROINJECTIONS; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PAIN MEASUREMENT; RATS; RATS, WISTAR; REACTION TIME; RESTRAINT, PHYSICAL; STEREOTAXIC TECHNIQUES; STRESS, PSYCHOLOGICAL;

ANIMALIA; RATTUS NORVEGICUS;

EID: 0036887559     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(02)00964-4     Document Type: Article

References (74)

1. Amit Z., Galina Z.H. Stress induced analgesia plays an adaptive role in the organization of behavioral responding. Brain Res. Bull. 21:1988;955-958.
2. Ayers N.A., Kapas L., Krueger J.M. The inhibitory effects of N omega-nitro-L-arginine methyl ester on nitric oxide synthase activity vary among brain regions in vivo but not in vitro. Neurochem. Res. 22:1997;81-86.
3. Babbedge R.C., Hart S.L., Moore P.K. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA. J. Pharmacol. 45:1993;77-79.
4. G-nitro-arginine p-nitroanilide (L-NAPNA) is antinociceptive in the mouse. NeuroReport. 4:1993;307-310.
5. Barjavel M.J., Bhargava H.N. Nitric oxide synthase activity in regions and spinal cord of mice and rats: kinetic analysis. Pharmacology. 50:1995;168-174.
6. Bechara A., Damasio H., Tranel D., Damasio A.R. Deciding advantageously before knowing the advantageous strategy. Science. 275:1997;1293-1295.
7. Bodnar R.J. Neuropharmacological and neuroendocrine substrates of stress-induced analgesia. Ann. NY Acad. Sci. 467:1986;345-360.
8. Bodnar R.J., Komisaruk B.R. Reduction in cervical probing analgesia by repeated prior exposure to cold-water swims. Physiol. Behav. 32:1984;653-655.
9. Bodnar R.J., Kelly D.D., Brutus M., Glusman M. Stress-induced analgesic: neural and hormonal determinants. Neurosci. Biobehav. Rev. 4:1980;87-100.
10. Bredt D.S., Snyder S.H. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. U.S.A. 87:1990;682-685.
11. Caggiula A.R., Antelman S.M., Aul E., Knopf S., Edwards D.J. Prior stress attenuates the analgesic response but sensitizes the corticosterone and cortical dopamine responses to stress 10 days later. Psychopharmacology (Berlin). 99:1989;233-237.
12. Calgnetti D.A., Holzman S.G. Factors affecting restraint stress-induced potentiation of morphine analgesia. Brain Res. 537:1990;157-162.
13. Ceccarelli I., Scaramuzzino A., Aloisi A.M. Effects of formalin pain on hippocampal c-Fos expression in male and female rats. Pharmacol., Biochem. Behav. 64:1999;797-802.
14. Contestabile A. Roles of NMDA receptor activity and nitric oxide production in brain development. Brain Res. Rev. 32:2000;476-509.
15. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. U.S.A. 88:1991;6368-6371.
16. de Oliveira R.M., Del Bel E.A., Mamede-Rosa M.L., Padovan C.M., Deakin J.F., Guimarães F.S. Expression of neuronal nitric oxide synthase mRNA in stress-related brain areas after restraint in rats. Neurosci. Lett. 289:2000;123-126.
17. Delgado J.M.R. Cerebral structures involved in transmission and elaboration of noxious stimulation. J. Neurophysiol. 18:1955;261-275.
18. Foy M.R., Stanton M.E., Levine S., Thompson R.F. Behavioral stress impairs long-term potentiation in rodent hippocampus. Behav. Neural Biol. 48:1987;138-149.
19. Garthwaite J. Glutamate, nitric oxide and cell-cell signaling in the nervous system. Trends Neurosci. 14:1991;60-67.
20. Givalois L., Arancibia S., Tapia-Arancibia L. Concomitant changes in CRH mRNA levels in rat hippocampus and hypothalamus following immobilization stress. Brain Res. Mol. Brain Res. 75:2000;166-171.
21. Gol A., Faibish G.M. Effects of human hippocampal ablation. J. Neurosurg. 26:1967;390-398.
22. Grau J.W., Hyson R.L., Maier S.F., Madden J., Barchas J.D. Long-term stress-induced analgesia and activation of the opiate system. Science. 213:1981;1409-1411.
23. Griffith O.W., Stuehr D.J. Nitric oxide synthases: properties and catalytic mechanism. Ann. Rev. Physiol. 57:1995;707-736.
24. Guimarães F.S., de Aguiar J.C., Del Bel E.A., Ballejo G. Anxiolytic effect of nitric oxide inhibitors microinjected into the dorsal central grey. NeuroReport. 5:1994;1929-1932.
25. Haley J.E., Dickenson A.H., Schachter M. Electrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat. Neuropharmacology. 31:1992;251-258.
26. Halgren E.R.D., Walter R.D., Cherlow D.G., Crandall P.H. Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain. 101:1978;83-117.
27. Harkin A.J., Bruce K.H., Craft B., Paul I.A. Nitric oxide synthase inhibitors have antidepressant-like properties in mice: 1. Acute treatment is active in the forced swim test. Eur. J. Pharmacol. 372:1999;207-213.
28. Haulica I., Busuioc A., Neamtu C., Dorneanu V., Titu G., Spac A. Possible involvement of the L-arginine-nitric oxide pathway in the modulation of stress-induced analgesia. Funct. Neurology. 10:1995;169-173.
29. Iwamoto E.T., Marion L. Pharmacological evidence that nitric oxide mediates the antinociception produced by muscarinic agonist in the rostral ventral medulla of rats. J. Pharmacol. Exp. Ther. 269:1994;699-708.
30. Jorum E. Analgesia or hyperalgesia following stress correlates with emotional behavior in rats. Pain. 32:1988;341-348.
31. Kawabata A., Umeda N., Takagi H. L-Arginine exerts a dual role in nociceptive processing in the brain: involvement of the kyotorphin-Met-enkephalin pathway and NO-cyclic GMP pathway. Br. J. Pharmacol. 109:1993;73-79.
32. Kawabata A., Manabe S., Manabe Y., Takagi H. Effect of topical administration of L-arginine on formalin-induced nociception in the mouse: a dual role of peripherally formed NO in pain modulation. Br. J. Pharmacol. 112:1994;547-550.
33. Khanna S., Sinclair J.G. Noxious stimuli produce prolonged changes in the CA1 region of rat hippocampus. Pain. 39:1989;337-343.
34. Khanna S., Sinclair J.G. Response in the CA1 region of the rat hippocampus to a noxious stimulus. Exp. Neurol. 117:1992;28-35.
35. Khanna S., Zheng F. Morphine reversed formalin-induced CA1 pyramidal cell suppression via an effect on septohippocampal neural processing. Neuroscience. 89:1999;61-71.
36. Klamt J.G., Prado W.A. Antinociception and Behavioral changes induced by carbachol microinjected into identified sites of the rat brain. Brain Res. 549:1991;9-18.
37. Kolesnikov Y.A., Pick C.G., Ciszewska G., Pasternak G.W. Blockade of tolerance to morphine but not to kappa opioids by a nitric oxide synthase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 90:1993;5162-5166.
38. Kumar A., Raghubir R., Srimal R.C., Dhawan B.N. Evidence for involvement of nitric oxide in pretectal analgesia in rat. NeuroReport. 4:1993;706-708.
39. Lico M.C., Hoffman A., Covian M.R. Influence of some limbic structures upon somatic and autonomic manifestation of pain. Physiol. Behav. 12:1974;805-811.
40. Lino de Oliveira C., Guimarães F.S., Del Bel E.A. c-jun mRNA expression in the hippocampal formation induced by restraint stress. Brain Res. 753:1997;202-208.
41. Madden J., Akil H., Patrick R.L., Barchas J.D. Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature. 265:1977;358-360.
42. Maier S.F. Stressor controllability and stress-induced analgesia. Ann. NY Acad. Sci. 467:1986;55-72.
43. McEwen B.S. Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22:1999;105-122.
44. McEwen B.S., Magarinos A.M. Stress effects on morphology and function of the hippocampus. Ann. NY Acad. Sci. 821:1997;871-884.
45. McKenna J., Melzack R. Analgesia produced by lidocaine microinjection into the dentate gyrus. Pain. 49:1992;105-112.
46. McKenna J.E., Melzack R. Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp. Neurol. 172:2001;92-99.
47. Melzack R., Casey K. Sensory, motivational and central control determinants of pain. Kenshalo D. The skin senses. 1968;423-439 Thomas, Springfield.
48. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
49. Moncada C.R., Arvin B., Meldrum B.S. The pyrimidine derivative BW 1003C87 protects against excitotoxic lesions induced by kainate in the rat striatum. Neurosci. Lett. 179:1994;17-20.
50. G-Arginine methyl ester exhibits antinociceptive activity in the mouse. Br. J. Pharmacol. 102:1991;198-202.
51. Padovan C.M., Guimarães F.S. Restraint-induced hypoactivity in an elevated plus-maze. Braz. J. Med. Biol. Res. 33:2000;79-83.
52. Paskitti M.E., McCreary B.J., Herman J.P. Stress regulation of adrenocorticosteroid receptor gene transcription and mRNA expression in rat hippocampus: time-course analysis. Brain Res. Mol. Brain Res. 80:2000;142-152.
53. Paxinos G., Watson C. The rat brain in stereotaxic coordinates. 2nd ed. 1986;Academic Press, New York.
54. Ploghaus A., Tracey I., Clare S., Gati J.S., Rawlins J.N., Matthews P.M. Learning about pain: the neural substrate of the prediction error for aversive events. Proc. Natl. Acad. Sci. U.S.A. 97:2000;9281-9286.
55. Prado W.A., Roberts M.H.T. An assessment of the antinociceptive and aversive effects of stimulating identified sites in the rat brain. Brain Res. 340:1985;219-228.
56. Price D.D. Psychological and neural mechanisms of the affective dimension of pain. Science. 288:2000;1769-1772.
57. Radomski M.W., Palmer R.M.J., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 87:1990;10043-10047.
58. Reagan L.P., McKittrick C.R., McEwen B.S. Corticosterone and phenytoin reduce neuronal nitric oxide synthase messenger RNA expression in rat hippocampus. Neuroscience. 91:1999;211-219.
59. Salter M., Duffy C., Garthwaite J., Strijbos P.J. Substantial regional and hemispheric differences in brain nitric oxide synthase (NOS) inhibition following intracerebroventricular administration of N omega-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology. 34:1995;639-649.
60. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry. 57:2000;925-935.
61. Shibuta S., Mashimoto T., Ohara A., Zhang P., Yoshiya I. Intraventricular administration of a nitric oxide-releasing compound, NOC-18, produces thermal hyperalgesia in rats. Neurosci. Lett. 187:1995;103-106.
62. Shors T.J., Dryver E. Effect of stress and long-term potentiation (LTP) on subsequent LTP and the theta burst response in the dentate gyrus. Brain Res. 666:1994;232-238.
63. Shors T.J., Gallegos R.A., Breindl A. Transient and persistent consequences of acute stress on long-term potentiation (LTP), synaptic efficacy, theta rhythms and bursts in area CA1 of the hippocampus. Synapse. 26:1997;209-217.
64. Spinella M., Bodnar R.J. Nitric oxide synthase inhibition selectively potentiates swim stress antinociception in rats. Pharmacol., Biochem. Behav. 47:1994;727-733.
65. Titze-de-Almeida R., de Oliveira C.L., Shida H.W., Guimarães F.S., Del Bel E.A. Midazolam and the N-methyl-D-aspartate (NMDA) receptor antagonist 2-amino-7-phosphonoheptanoic acid (AP-7) attenuate stress-induced expression of c-fos mRNA in the dentate gyrus. Cell. Mol. Neurobiol. 14:1994;373-380.
66. Valtschanoff J.G., Weinberg R.J., Kharazia V.N., Nakane M., Schmidt H.H. Neurons in rat hippocampus that synthesize nitric oxide. J. Comp. Neurol. 331:1993;111-121.
67. Vidal C., Jacob J. Hyperalgesia induced by non-noxious stress in the rat. Neurosci. Lett. 32:1982;75-80.
68. Vidal C., Jacob J.J. Stress hyperalgesia in rats: an experimental animal model of anxiogenic hyperalgesia in human. Life Sci. 31:1982;1241-1244.
69. Vidal C., Jacob J. Hyperalgesia induced by emotional stress in the rat: an experimental animal model of human anxiogenic hyperalgesia. Ann. NY Acad. Sci. 467:1986;73-81.
70. Volke V., Koks S., Vasar E., Bourin M., Bradwejn J., Mannisto P.T. Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze. NeuroReport. 6:1995;1413-1416.
71. Weber C.M., Eke B.C., Maines M.D. Differential effects of maternal stress on circulating levels of corticosterone, progesterone, and testosterone in male and female fetuses and their mother. Endocrinology. 114:1994;1635-1644.
72. Wendland B., Schweizer F.E., Ryan T.A., Nakane M., Murad F., Scheller R.H., Tsien R.W. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;2151-2155.
73. Xu L., Anwyl R., Rowan M.J. Behavioural stress facilitates the induction of long-term depression in the hippocampus. Nature. 387:1997;497-500.
74. Zhuo M., Meller S.T., Gebhart G.F. Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain. 54:1993;71-78.